Related Experiment Video
Updated: May 2, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Induction immunosuppressive therapy in kidney transplantation
Mohamed Adel Bakr1, Ayman Maher Nagib, Ahmed Farouk Donia
1Urology Nephrology Center, Mansoura University, Mansoura, Egypt.
Kidney transplant recipients receive intensive induction therapy to prevent rejection. Doses are adjusted to minimize side effects and optimize graft survival, with specific protocols for unique patient situations.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Kidney transplantation requires intensive immunosuppression post-surgery to prevent acute rejection.
- Early immunosuppression targets the recipient's immune response to donor antigens.
- Minimizing long-term immunosuppression is crucial to reduce drug-related adverse events.
Conclusions:
- Induction therapy is a critical component of kidney transplant management.
- Tailoring immunosuppression is essential for optimizing outcomes in diverse recipient and donor scenarios.
- Adherence to clinical practice guidelines aids in selecting appropriate induction regimens.
More Related Videos
10:29Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cell-mediated Immune Responses